KATHERINE BAKER: Open Payments
NPI 1891068896 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 26 payments from 12 companies in 2025. Trend: 2023 $2,211 · 2024 $173 · 2025 $659
Food & beverage: $659
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $225 |
| Medtronic, Inc. | 2 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| COLOPLAST CORP | 2 | $53 |
| Abbott Laboratories | 2 | $43 |
| Boston Scientific Corporation | 1 | $38 |
| Ferring Pharmaceuticals Inc. | 1 | $33 |
| Teleflex LLC | 1 | $31 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
Products named: ERLEADA, RYBREVANT, INTERSTIM, Nubeqa, FREESTYLE LIBRE, LithoVue, ADSTILADRIN, BARRIGEL.
Industry payments across MO — which companies pay providers there.
